The following themes are broad and inclusive and may assist with guidance for your submission. You will be asked to nominate your preferred theme(s) during the submission process: 

• Clinical and phenomenological aspects of Neuropsychiatry
• Genetics, biomarkers including neuroimaging 
• Immune and Inflammatory aspects in Neuropsychiatry
• Functional Neurological Disorders
• Neuropsychiatric sequelae of neurological disorders (e.g. Parkinson's, epilepsy)
• Neuropsychiatric aspects of psychiatric and addiction disorders
• Neurodevelopmental disorders (e.g. Tics/Tourette, ADHD, ASD, OCD)
• Sleep and related disorders
• Consumer and Community Involvement, Participatory research, quality of life
• Neurodegenerative conditions, dementia
• Non-pharmacological, emerging and novel treatments in neuropsychiatry

Abstract review notifications will be communicated to the presenting author on Monday 15 July 2024.

Please note the details provided as the author contact should be for the nominated main contact for your abstract. All correspondence relating to the submission will be directed to this person and they should in turn distribute to all co-presenters if applicable.

Acceptance of the offer must be confirmed by Wednesday 31 July 2024.

The invitation to submit an abstract or a subsequent offer to present an oral, symposium or poster presentation does not constitute an offer to pay travel, accommodation or registration costs associated with the Congress.  All presenters must register for the Congress in order for the presentation to be included in the Congress program.

Before finalising the abstract submission, you will be asked to consider and agree to the terms and conditions detailed in the submission portal.